Health Conversation EFPIA
-
- Salud y forma física
Have questions about the healthcare industry? Welcome to Health Conversation, where we will discuss today’s challenges and how we’re preparing for the future.
Presented by the European Federation of Pharmaceutical Industries and Association.
Hosted on Acast. See acast.com/privacy for more information.
-
How can we navigate COVID-19 in a new winter health landscape?
Welcome to Health Conversation. Today we're asking Jo Atkinson, Anti-Infectives Product Lead at Pfizer, 'How can we navigate COVID-19 in a new winter health landscape?'. Listen to hear their discussion on the challenge and how we're preparing for the future.
Hosted on Acast. See acast.com/privacy for more information. -
What is the waiver impact on innovation and pandemic preparedness?
Welcome to Health Conversation. Today we're asking Claire Skentelbery, Director General of EuropaBio, 'What is the waiver impact on innovation and pandemic preparedness?'. Listen to hear their discussion on the challenge and how we're preparing for the future.
Hosted on Acast. See acast.com/privacy for more information. -
Why is a therapeutics waiver extension different to the vaccine waiver?
Welcome to Health Conversation. Today we're asking Koen Berden, Executive Director for International Affairs at EFPIA, 'Why is a therapeutics waiver extension different to the vaccine waiver?'. Listen to hear their discussion on the challenge and how we're preparing for the future.
Hosted on Acast. See acast.com/privacy for more information. -
What would a TRIPS waiver extension mean for diagnostics?
Welcome to Health Conversation. Today we're asking Jesús Rueda Rodríguez, Strategies, Special Projects & International Affairs Director General at MedTech Europe, 'What would a TRIPS waiver extension mean for diagnostics?'. Listen to hear their discussion on the challenge and how we're preparing for the future.
Hosted on Acast. See acast.com/privacy for more information. -
What would be the impact of a TRIPS waiver extension?
Welcome to Health Conversation. Today we're asking Peter Guenter, CEO of Healthcare at Merck, 'What would be the impact of a TRIPS waiver extension?'. Listen to hear their discussion on the challenge and how we're preparing for the future.
Hosted on Acast. See acast.com/privacy for more information. -
How can we support medical innovation in Europe?
Welcome to Health Conversation. Today we're asking Nathalie Moll, Director General at EFPIA, 'How can we support medical innovation in Europe?'. Listen to hear their discussion on the challenge and how we're preparing for the future.
Hosted on Acast. See acast.com/privacy for more information.